1. Calcific uraemic arteriolopathy in a patient with end‐stage renal failure and chronic plaque psoriasis: could TNF‐α inhibition help ameliorate disease progression?. (February 2015) Authors: Robinson, Aaron James; Nicolopoulos, Jenny; Pedagogos, Eugenie; Radulski, Barbara; Varigos, George A. Journal: Australasian journal of dermatology Issue: Volume 56:Number 1(2015:Feb.) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Calcific uraemic arteriolopathy in a patient with end‐stage renal failure and chronic plaque psoriasis: could TNF‐α inhibition help ameliorate disease progression?. (February 2015) Authors: Robinson, Aaron James; Nicolopoulos, Jenny; Pedagogos, Eugenie; Radulski, Barbara; Varigos, George A. Journal: Australasian journal of dermatology Issue: Volume 56:Number 1(2015:Feb.) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Measuring treatment response to adalimumab in hidradenitis suppurativa patients: An observational study. (17th February 2020) Authors: Kok, Yonatan; Nicolopoulos, Jenny; Braue, Anna; Kern, Johannes S.; Varigos, George; Dolianitis, Con Journal: Australasian journal of dermatology Issue: Volume 61:Number 3(2020) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pseudolymphoma induced by secukinumab for treatment of chronic plaque psoriasis. (21st February 2019) Authors: Cranwell, William C; Doolan, Brent J; Radulski, Barbara; Nicolopoulos, Jenny; Dolianitis, Con Journal: Australasian journal of dermatology Issue: Volume 60:Number 3(2019) Page Start: e246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution. (17th March 2021) Authors: Kok, Yonatan; Nicolopoulos, Jenny; Dolianitis, Con Journal: Australasian journal of dermatology Issue: Volume 62:Number 2(2021) Page Start: e313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tildrakizumab in the treatment of moderate‐to‐severe hidradenitis suppurativa. (6th July 2020) Authors: Kok, Yonatan; Nicolopoulos, Jenny; Howard, Anne; Varigos, George; Kern, Johannes; Dolianitis, Con Journal: Australasian journal of dermatology Issue: Volume 61:Number 4(2020) Page Start: e488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tildrakizumab in the treatment of PASH syndrome: A potential novel therapeutic target. (13th April 2020) Authors: Kok, Yonatan; Nicolopoulos, Jenny; Varigos, George; Howard, Anne; Dolianitis, Con Journal: Australasian journal of dermatology Issue: Volume 61:Number 3(2020) Page Start: e373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Topical dapsone gel for treatment of axillary subcorneal pustular dermatosis. Issue 11 (24th June 2019) Authors: Doolan, Brent J.; Cranwell, William C.; Nicolopoulos, Jenny; Dolianitis, Con Journal: Journal of dermatology Issue: Volume 46:Issue 11(2019) Page Start: e437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗